According to a new market report published by Lucintel, the future of the genotyping market looks promising with opportunities in diagnostics, drug discovery personalized medicine, academic research, and agriculture applications. The global genotyping market is expected to grow with a CAGR of 22.5% from 2020 to 2025. The major drivers for this market are increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, and technological advancement in gene studies.
To download report brochure, please go to https://www.lucintel.com/genotyping-market.aspx and click "download brochure" tab from the menu
Genotyping is the process to understand the genetic structure of any living organisms, such as humans, animals, plants, and microorganisms. In this market, reagents and kits, instruments, and services are the major product types. Lucintel forecasts that reagents and kits will remain the largest product segment over the forecast period due to a wide usage rate, surging demand for genotyping tests, cost-effectiveness, and easy availability of reagents.
Within this market, personalized medicine will remain the largest application segment over the forecast period due to rising government support for personalized medicine, changing reimbursement and regulatory landscape, and the growing adoption of sequencing for genetic mapping.
North America will remain the largest region over the forecast period due to the well-established healthcare infrastructure and rapid advancements in technology in the region.
QIAGEN, Affymetrix, Illumina, Thermo Fisher Scientific, General Electric, Agilent Technologies, and Roche are among the major suppliers in the global genotyping market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global genotyping market by product, technology, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Genotyping Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global genotyping market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents and Kits
Instruments
Services
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
PCR (Polymerase Chain Reaction)
Capillary Electrophoresis
Mass Spectrometry
Sequencing
Microarray
Others
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Diagnostics
Drug Discovery and Development
Personalized Medicine
Academic Research
Agricultural Biotechnology and Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical & Biopharmaceutical Companies
Diagnostic & Research Laboratories
Academic Institutes
Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.